Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2026-04-08 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Share Issue/Capital Change Classification · 1% confidence The document is the HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” detailing movements in authorised/registered share capital, issued shares, share options and public float for the month ended 31 March 2026. This is a regulatory submission concerning changes in the company’s capital structure and share movements under Chapter 19B of the Listing Rules. It is not an earnings announcement, board change or dividend notice, but a share capital change disclosure. Therefore, it should be classified as Share Issue/Capital Change (SHA).
2026-04-08 English
VOLUNTARY ANNOUNCEMENT CHANGE IN SHAREHOLDING
Major Shareholding Notification Classification · 1% confidence The document is a voluntary announcement by Uni-Bio Science Group detailing a change in shareholding structure among entities controlled by the chairman and his family. There is no issuance or repurchase by the company (eliminating SHA and POS), nor is it an earnings release, dividend notice, or meeting material. It reports a significant shareholder’s internal transfer of shares and ongoing control, matching the description of a Major Shareholding Notification. Therefore, the correct classification is MRQ.
2026-04-02 English
Finial Dividend for the year ended 31 December 2025 and Closure of Register of Members
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement of the final dividend for the year ended 31 December 2025, including dividend amount per share, ex-dividend date, record date, payment date, and register closure details. This fits the description of a "Notice of Dividend Amount".
2026-03-27 English
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
Earnings Release Classification · 1% confidence The document is titled “Announcement of Final Results for the Year Ended 31 December 2025” and contains the company’s audited full-year results, key financial highlights, segment information, and a detailed management discussion and analysis. This exactly matches the profile of an earnings release announcing periodical financial results (albeit for a full year rather than a quarter). It is not the full formal annual report (which would include the auditor’s report, notes to the financial statements, corporate governance statements, etc.), nor is it a mere notice of publication. Therefore, it should be classified as an Earnings Release. FY 2025
2026-03-27 English
PROPOSED AMENDMENTS AND ADOPTION OF THE SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is an official announcement by a Hong Kong-listed company regarding proposed amendments to its Articles of Association – the company’s constitutional governance document. This falls squarely under “Governance Information” as it deals with internal rules and corporate governance structure, rather than being a meeting notice, dividend, director change, or financial report.
2026-03-27 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short announcement (1524 characters) from Uni-Bio Science Group Limited regarding the scheduling of a board meeting to approve upcoming financial results and discuss dividends. It does not contain the financial results themselves, but rather serves as a notification of the meeting date. According to the 'Menu vs Meal' rule, announcements regarding the timing or publication of reports are classified as Report Publication Announcements (RPA).
2026-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.